These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 4576244)
1. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity]. Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244 [No Abstract] [Full Text] [Related]
2. Dantrolene sodium: long-term effects in severe spasticity. Chyatte SB; Basmajian JV Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936 [No Abstract] [Full Text] [Related]
3. The effect of dantrolene sodium on spasticity in multiple sclerosis. Gelenberg AJ; Poskanzer DC Neurology; 1973 Dec; 23(12):1313-5. PubMed ID: 4796610 [No Abstract] [Full Text] [Related]
4. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease. Weiser R; Terenty T; Hudgson P; Weightman D Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589 [No Abstract] [Full Text] [Related]
5. Dantrolene sodium for treatment of spasticity. Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632 [No Abstract] [Full Text] [Related]
6. Spasticity and the effect of dantrolene sodium. Monster AW Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132 [No Abstract] [Full Text] [Related]
7. The effect of Dantrium on spasticity in multiple sclerosis. Ladd H; Oist C; Jonsson B Acta Neurol Scand; 1974; 50(4):397-408. PubMed ID: 4277694 [No Abstract] [Full Text] [Related]
8. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Glass A; Hannah A Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209 [No Abstract] [Full Text] [Related]
9. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)]. Gonsette RE; Capart T; Demonty L Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084 [TBL] [Abstract][Full Text] [Related]
10. Dantrolene sodium: long-term effects in patients with muscle spasticity. Joynt RL Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122 [TBL] [Abstract][Full Text] [Related]
12. Dantrolene sodium in children with spasticity. Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292 [No Abstract] [Full Text] [Related]
13. Cooperative study for assessing the effects of a pharmacological agent on spasticity. Monster AW; Herman R; Meeks S; McHenry J Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384 [No Abstract] [Full Text] [Related]
18. Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report. Sturgill EL; Wittwer RL A A Pract; 2018 Jul; 11(1):25-27. PubMed ID: 29851691 [TBL] [Abstract][Full Text] [Related]
19. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm]. Couto B; Figuereido HB; Araújo Leitão RE; Alvarenga H; Gomes Marleide M; Melo Reis CH Neurol Neurocir Psiquiatr; 1976; 17(4):213-21. PubMed ID: 1018726 [TBL] [Abstract][Full Text] [Related]
20. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Pinder RM; Brogden RN; Speight TM; Avery GS Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]